 
Convergence of Type 2 Diabetes and Cardiovascular
Disease
In conjunction with
Southern Medical Association 2009 Annual Scientific Assembly
Program Chair: Donna Polk, MD, FACC
Friday, December 4, 2009
7:00 a.m. – 8:30 a.m.
Gaylord Texan Resort
Dallas, Texas
 |
Learning Pathway: General Cardiology: Hypertension,
Lipids and Prevention
|
| The ACCF is pleased to present
a two-year educational initiative on The Convergence of
Diabetes and Cardiovascular Disease: Current Insights and
Future Directions which will incorporate comprehensive
needs assessment, program planning, evaluation and outcomes,
and educational interventions that broaden the emphasis from
knowledge dissemination to change in clinical practice, behavior
and outcomes. Click
here for further information on this
initiative.
|
PROGRAM
OVERVIEW
Statement of Need
Recent studies have identified the clear correlation between coronary
heart disease and type 2 diabetes mellitus. Diabetes increases the
risk of coronary artery disease (CAD) by a factor of 2- to 4-fold.
Myocardial ischemia is a major complication in the course of diabetes,
causing 75% of diabetes-related deaths. Patients with diabetes also
have a higher rate of sudden death and poorer outcomes after myocardial
infarction (MI). Compared with a non-diabetic individual, a person
with type 2 diabetes has a 2- to 4-fold risk of dying from MI or
a stroke and a 10- to 15-fold increased risk of lower extremity
amputation. In addition mortality among diabetic patients from a
coronary artery incident is rising. In fact more than 65% of people
with diabetes die from heart disease or stroke.
Despite ongoing dissemination of evidence-based guidelines for
health care professionals and patients, there remains an estimated
20 million people in the United States, 7% of the population, who
suffer from diabetes which is a significant cause of morbidity and
disability. To address this need, the American College of Cardiology
Foundation is conducting a two-year initiative to increase awareness
and education to medical professionals on the intersection of cardiovascular
disease and type 2 diabetes mellitus.
Overview
Join the American College of Cardiology during the Southern Medical
Association 2009 Annual Scientific Assembly for a stimulating breakfast
session on The Convergence of Type 2 Diabetes and Cardiovascular
Disease. The expert faculty will examine the clear correlation
between coronary heart disease and type 2 diabetes mellitus and
developments in this dynamic field. Participants will have an opportunity
to participate in question and answer sessions and discuss case
presentations.
Learner Objectives
The overall goal of this session is to enhance participants’
competence by providing the most up-to-date information on the correlation
of type 2 diabetes and cardiovascular disease.
Upon completion of this program, attendees should be able to —
- Describe the prevalence of CV disease in patients with diabetes
- Identify patients with known diabetes and those at risk for
diabetes, who are at significantly increased risk for CV disease
based on the most current screening and treatment guidelines
- Apply modifiable and controllable risk factor strategies in
the daily management of patients with diabetes and/or CV disease,
to achieve evidence-based optimal outcomes
FACULTY
Program Chair
Donna Polk, MD, FACC
Director Preventive Cardiology
Henry Low Heart Center
Director Women’s Heart Program
Hartford Hospital
Hartford, CT
Nurse Planner/Content Expert
Suzanne Hughes, MSN, RN
Director, Patient and Community Education and Research
Robinson Memorial Hospital
Hudson, OH
Invited Faculty
Darren Keith McGuire, MD, FACC
Assistant Professor of Medicine
University of Texas-Southwestern Medical Center at Dallas
Dallas, TX
Amit Khera, MD, FACC
Assistant Professor
University of Texas Southwestern Medical Center at Dallas
Dallas, TX
DISCLOSURES
ACCF faculty, committee members, staff and other
individuals who are in a position to control the content of this
activity are required to disclose all real or apparent conflicts
of interest. All relevant potential conflicts of interest that are
identified are thoroughly vetted through a process that includes
course directors and appropriate peer review by education committee
chairs/members, for fair balance, scientific objectivity and validity,
patient care and safety recommendations. Refer to the links below
for committee member disclosures and program faculty disclosures.
Please note ACCF staff involved with this program have nothing to
disclose.
ACC
Live Programs Committee (2007-2010) disclosures
Convergence
of Type 2 Diabetes and Cardiovascular Disease Faculty disclosures
AGENDA
The Southern Medical Association 2009 Annual Scientific Assembly
will be held December 3 - 5, 2009. For complete program information
click here.
The ACCF Convergence of Type 2 Diabetes and Cardiovascular Disease
breakfast session will be held December 4, 2009 from 7:00 a.m. to
8:30 a.m. Breakfast will be provided.
LEARNER BILL
OF RIGHTS
Learner
Bill of Rights
TARGET
AUDIENCE
This program is intended for physicians, physician
assistants, Fellows in Training, nurses, nurse practioners and others
interested in the relationship between type 2 diabetes and cardiovascular
disease.
ACCREDITATION
Physicians
The American College of Cardiology Foundation is accredited by the
Accreditation Council for Continuing Medical Education to provide
continuing medical education for physicians.
The ACCF designates this educational activity for a maximum of
1.5 AMA PRA Category 1 Credits™. Physicians should
only claim credits commensurate with the extent of their participation
in the activity.
Nurses
The American College of Cardiology Foundation is accredited as a
provider of continuing nursing education by the American Nurses
Credentialing Center’s Commission on Accreditation.
The ACCF designates this educational activity for a maximum of
1.5 continuing education hours. Requirements for successful completion
are attendance in a session in its entirety and completing the evaluation
tool. Each attendee should only claim credits commensurate with
the extent of their participation in the activity.
While offering credits noted above, the program is not intended
to provide extensive training or certification in the field.
REGISTRATION
To register for the Southern Medical Association 2009 Annual Scientific
Assembly click
here.
You may register for the ACCF Convergence of Type 2 Diabetes and
Cardiovascular Disease breakfast program once you have registered
for the Southern Medical Association 2009 Annual Scientific Assembly.
Pre-registration is not required, but preferred. Priority will
be given to pre-registrants. On-site registration will be available
prior to the start, space permitting. Please bring your SMA name
badge to the event. Sorry, guests are not permitted to attend.
ACCOMMODATIONS
Location
The program will be held at the Gaylord
Texan Resort, 1501 Gaylord Trail, Dallas, TX 76051. The meeting
site telephone number is (817) 778-2000.
GENERAL
INFORMATION
Tuition
There is no fee to attend the ACCF Convergence of Type 2 Diabetes
and Cardiovascular Disease program; however, there is a fee to attend
the Southern Medical Association 2009 Annual Scientific Assembly.
Participants of the ACCF Convergence of Type 2 Diabetes and Cardiovascular
Disease program will receive breakfast and an electronic syllabus.
Please Note
We encourage participation by all individuals. If you have a disability,
advance notification of any special needs will help us serve you
better.
Videotaping, audiotaping and still photography are prohibited in
all ACCF meeting rooms.
Faculty and program are subject to change without notice.
Accredited status does not imply endorsement by the ACCF of any
commercial products displayed in conjunction with this activity.
The views expressed in this program are those of the individual
speaker and do not necessarily reflect the views of ACCF.
ACKNOWLEDGMENTS
Major support for this activity is provided through
an educational grant from:
Additional support is provided through an educational grant from:
|
